Showing results (81-90 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|February 16, 2026
Impact of single versus dual local anaesthetic regimen on the efficacy and safety of percutaneous stellate ganglion block for electrical storm: new insights from the STAR studyAlessia Currao, Veronica Dusi, Matteo Casula, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 18, 2025
Emerging antihypertensive therapies and cardiovascular, kidney, and metabolic outcomes: a Mendelian randomization studyNhu Ngoc Le, Tran Quoc Bao Tran, John McClure, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2025
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trialTakenori Domei, Ko Yamamoto, Masahiro Natsuaki, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 13, 2024
Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndromeWout Willem Antoon van den Broek, Jaouad Azzahhafi, Dean R P P Chan Pin Yin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 20, 2025
Apixaban outcomes in AF patients with single dose-reduction criterion: ASPIRE 1-year resultsSo-Ryoung Lee, JungMin Choi, Soonil Kwon, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 18, 2024
Phosphodiesterase 5 and its inhibitors with ischaemic heart disease: a Mendelian randomization analysis and a real-world studyJun Xiao, Naiqi Zhang, Ziting Gao, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 25, 2024
Polygenic risk, aspirin, and primary prevention of coronary artery diseaseChenglong Yu, Pradeep Natarajan, Aniruddh P Patel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 15, 2024
Role of PCSK9 inhibitors in venous thromboembolism: current evidence and unmet clinical needsMarco Zuin, Alberto Corsini, Chiara Dalla Valle, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 31, 2024
Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseasesBurkhard Weisser, Sven Wassmann, Hans-Georg Predel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 9, 2024
Estimated impact of guidelines-based initiation of dual antihypertensive therapy on long-term cardiovascular outcomes in 1.1 million individualsAntonio Coca, Claudio Borghi, George S Stergiou, et al.
Pageof 53